~ Buy the ELUCIREM (gadopiclenol) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR ELUCIREM

All Clinical Trials for ELUCIREM

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT05590884 ↗	Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of Age	Recruiting	Guerbet	Phase 2	2022-09-21	This Phase II open-label, uncontrolled, multicenter trial is designed to investigate the pharmacokinetic (PK) profile of gadopiclenol in plasma, in pediatric patients aged up to 23 months inclusive (term neonates or preterm infants after the neonatal period), using a population PK approach. Primary objective is to evaluate the PK profile of gadopiclenol in plasma following single intravenous injection of 0.05 mmol/kg body weight (BW) in pediatric population aged up to 23 months (inclusive) scheduled for a contrast-enhanced MRI examination of any body region including central nervous system (CNS).

Clinical Trial Conditions for ELUCIREM

Condition Name

Condition Name for ELUCIREM
Intervention	Trials
Body Indication	1
Central Nervous System Diseases	1
Pediatric Disorder	1

Condition MeSH

Condition MeSH for ELUCIREM
Intervention	Trials
Nervous System Diseases	1
Central Nervous System Diseases	1

Clinical Trial Locations for ELUCIREM

Trials by Country

Trials by Country for ELUCIREM
Location	Trials
United States	2
Hungary	1
Bulgaria	1
Poland	1

Trials by US State

Trials by US State for ELUCIREM
Location	Trials
South Carolina	1
Ohio	1

Clinical Trial Progress for ELUCIREM

Clinical Trial Phase

Clinical Trial Phase for ELUCIREM
Clinical Trial Phase	Trials
Phase 2	1

Clinical Trial Status

Clinical Trial Status for ELUCIREM
Clinical Trial Phase	Trials
Recruiting	1

Clinical Trial Sponsors for ELUCIREM

Sponsor Name

Sponsor Name for ELUCIREM
Sponsor	Trials
Guerbet	1

Sponsor Type

Sponsor Type for ELUCIREM
Sponsor	Trials
Industry	1